Parkman Healthcare Partners LLC Neurocrine Biosciences Inc Transaction History

Parkman Healthcare Partners LLC

$687 Million
Q4 2024

A detailed history of Parkman Healthcare Partners LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 115,727 shares of NBIX stock, worth $14 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares

115,727

Previous 129,840 10.87%

Holding current value

$14 Million

Previous $14.9 Million 5.67%

% of portfolio

2.3%

Previous 2.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$111.62 - $139.44 $1.58 Million - $1.97 Million	-14,113 Reduced 10.87%	115,727 $15.8 Million
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $1.68 Million - $2.25 Million	14,670 Added 12.74%	129,840 $14.9 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $2.2 Million - $2.4 Million	-16,781 Reduced 12.72%	115,170 $15.9 Million
Q1 2024 May 15, 2024	SELL	$130.4 - $143.74 $1.06 Million - $1.17 Million	-8,165 Reduced 5.83%	131,951 $18.2 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $5.97 Million - $7.47 Million	56,271 Added 67.11%	140,116 $18.5 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $5.25 Million - $6.54 Million	-55,890 Reduced 40.0%	83,845 $9.43 Million
Q2 2023 Aug 11, 2023	SELL	$89.53 - $104.87 $6.99 Million - $8.19 Million	-78,103 Reduced 35.85%	139,735 $13.2 Million
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $9.55 Million - $12.5 Million	101,505 Added 87.25%	217,838 $22 Million
Q4 2022 Feb 13, 2023	SELL	$106.72 - $127.06 $113,870 - $135,573	-1,067 Reduced 0.91%	116,333 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $2.93 Million - $3.43 Million	31,811 Added 37.17%	117,400 $12.5 Million
Q2 2022 Aug 12, 2022	BUY	$75.79 - $100.07 $1.69 Million - $2.24 Million	22,355 Added 35.35%	85,589 $8.34 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $4.58 Million - $6 Million	63,234 New	63,234 $5.93 Million
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $11.5 Million - $14.4 Million	-132,544 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $1.06 Million - $1.49 Million	11,018 Added 9.07%	132,544 $12.7 Million
Q2 2020 Aug 13, 2020	SELL	$85.09 - $130.36 $595,630 - $912,520	-7,000 Reduced 5.45%	121,526 $14.8 Million
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $2.02 Million - $3.06 Million	-26,899 Reduced 17.31%	128,526 $11.1 Million
Q4 2019 Feb 13, 2020	BUY	$86.8 - $118.57 $13.5 Million - $18.4 Million	155,425 New	155,425 $16.7 Million

Others Institutions Holding NBIX

# of Institutions

654

Shares Held

96.5M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Account

Parkman Healthcare Partners LLC Neurocrine Biosciences Inc Transaction History